Glycogen Storage Disease Type III (Glucogen Debranching Enzyme Def) :Biochem Defects & Myopathy & Cardiomyopathy
Ann Int Med 116:896-900, Coleman,R.A.,et al, 1992
Autoantibody Against Oxidised LDL and Progression of Carotid Atherosclerosis
Lancet 339:883-900, Salonen,J.T.,et al, 1992
Antibodies to Oxidised LDL in Atherosclerosis
Editorial, Lancet 339:899-9001992., , 1992
Ticlopidine for Prevention of Stroke
The Medical Letter, 34:65-661992., , 1992
Lioporotein and Apolipoprotein Profile in Men with Ischemic Stroke
Stroke 23:1556-1562, Pedro-Botet,J.,et al, 1992
Bovine Gangliosides and Acute Motor Polyneuropathy
BMJ 305:1330-1331, Figueras,A.,et al, 1992
Gangliosides and Neurological Diseases, Their Use in Humans Should be Suspended
BMJ 305:1309-1310, Behan,P.O., 1992
McArdle's Disease with Late-Onset Symptoms:Case Report & Review of the Literature
JNNP 55:407-408, Felice,K.J.,et al, 1992
GM-1 Ganglioside for Spinal-Cord Injury
NEJM 326:493, Schonhofer,P.S., 1992
Stroke-Like Syndrome, Mineralizing Microangiopathy, and Neuroaxonal Dyst with Intrathecal Methotrexate
Neurol 41:1847-1848, Phanthumchinda,K.,et al, 1991
Fibrinogen and Lipid Concentrations as Risk Factors for Transient Ischemic Attacks & Minor Ischaemic Strokes
BMJ 303:605-609, Qizilbash,N.,et al, 1991
Serum Cholesterol Concentration and Risk of Primary Brain Tumours
BMJ 302:90, Knekt,P.,et al, 1991
Gemfibrozil-Induced Myopathy
Arch Int Med 151:1873-1874, Magarian,G.J.,et al, 1991
Cholesterol-Lowering Agent Myopathy (CLAM)
Neurol 41:1159-1160, London,S.F.,et al, 1991
Recovery of Motor Function after Spinal-cord Injury-A Randomized, Placebo-Contrlled Trial with GM-1 Ganglioside
NEJM 324:1829-1838, 1885-18871991., Geisler,F.H.,et al, 1991
Adult Phosphorylase b Kinase Deficiency
Ann Neurol 28:529-538, Clemens,P.R.,et al, 1990
Myopathy and Rhabdomyolysis Associated with Lovastatin-Gemfibrozil Combination Therapy
JAMA 264:71-75, Pierce,L.R.,et al, 1990
Lower Motor Neuron Disease in a Patient with Autoantibodies Against Gangliosides GM1 and GD1b:Improvement with Immunotherapy
Neurol 40:842-844, Shy,M.E.,et al, 1990
Tangier Disease in a Black Patient:An Unusual Clinical Presentation
Am J Med 89:105-108, Lo,W.D.,et al, 1990
Cerebrotendinous Xanthomatosis:Clinical and MRI Study (A Case Report)
JNNP 53:76-78, Fiorelli,M.,et al, 1990
Serum Cholesterol and Hemorrhagic Stroke in the Honolulu Heart Program
Stroke 20:1460-1465, Katsuhiko,Y.,et al, 1989
Prediction of Carotid Stenosis Progression by Lipid & Hematologic Measurements
Neurol 39:1325-1331, Grotta,J.C.,et al, 1989
Atherosclerosis:Current Concepts on Pathogenesis and Interventional Therapies
Ann Neurol 26:3-12, Yatsu,F.M.&Fisher,M., 1989
Plasma Lipoproteins in Cortical Versus Lacunar Infarction
Stroke 20:448-452, Adams,R.J.,et al, 1989
Serum Cholesterol Levels & Six-Year Mortality from Stroke in 350, 977 Men Screened for Multiple Risk Factor Interven Trial
NEJM 320:904-910, Iso,H.,et al, 1989
Plasma Cholesterol Concentration and Primary Brain Tumors
BMJ 299:26-27, Davey,G.,et al, 1989
Hysterical Conversion Reactions Mimicking Neurological Disease
Am J Dis Child 142:1203-1206, Bangash,I.H.,et al, 1988
Regional Pain is Rarely Hysterical
Arch Neurol 45:915-918, Merskey,H., 1988
Risk of Brain Infarction in Familial Hypercholesterolemia
Stroke 19:1097-1100, Kaste,M.&Koivisto,P., 1988
McArdle's Disease:Biochemical and Molecular Genetic Studies
Ann Neurol 24:774-781, Servidei,S.,et al, 1988
Serum Antibodies to GM1 Ganglioside in Amytrophic Lateral Sclerosis
Neurol 38:1457-1461, Pestronk,A.,et al, 1988
Retinitis Pigmentosa
Surv Ophthalmol 33:137-177, Pagon,R.A., 1988
Relation Between Blood Lipids, Lipoproteins, and Cerebrovascular Atherosclerosis:A Review
Stroke 19:423-430, Tell,G.S.,et al, 1988
Mineralization of the Basal Ganglia Detected by CT in Hallervorden-Spatz Syndrome
Neurol 38:154-155, Tennison,M.B.,et al, 1988
Brief Communication: Psychogenic Sensory Loss
J Nerv Ment Dis 176:686-687, Rolak,L.A., 1988
CT in Ceroid Lipofuscinosis
Neurol 37:1025-1026, Dunn,D.W., 1987
Hyperlipidemia is a Risk Factor for Decreased Cerebral Perfusion & Stroke
Arch Neurol 44:418-422, Meyer,J.S.,et al, 1987
Prophylaxis of Atherosclerosis with Marine Omega-3 Fatty Acids, A Comprehensive Study
Ann Int Med 107:890-899, VonSchacky,C., 1987
Phosphorylase Deficiency
In Englel & Banker, Myology, McGraw-Hill Book Co, Ch 52, 1585-1601, DiMauro,S.&Bresolin,N., 1986
Acid Maltase Deficiency
Engel, A. G. in Engel and Banker, Myology, McGraw-Hill Co, New York, Ch 55, p. 1629-1651, , 1986
Clinicopath Conf
Myopathy Due to Adult Acid Maltase Deficiency, 36-1986, NEJM 315:694-701986., , 1986
Progressive Myoclonus Epilepsies:Specific Causes & Diagnosis
NEJM 315:296-305, Berkovic,S.F.,et al, 1986
Migraine in Children:Association with Primary & Familial Dyslipoproteinemias
Pediatrics 77:316, Glueck,C.J.&Bates,S.R., 1986
Familial Hyperlipidemia in Stroke in the Young
Stroke 17:1142-1145, Bansal,B.C.,et al, 1986
McArdle's Disease in the 1980s
NEJM 312:370-371, Layzer,R.B., 1985
Treatment of Peripheral Neuropathies
JNNP 48:1193-1207, Hallett,M.,et al, 1985
High Density Lipoprotein Cholesterol in Differential Diagnosis of Senile Dementia
Lancet 1:1191-1193, Muckle,T.J.,et al, 1985
Hyperlipidemic Dementia
Neurol 35:1385-1387, Mas,J.,et al, 1985
The Role of Plasma Lipids in Carotid Bifurcation Atherosclerosis
Ann Neurol 17:301-303, Ford,C.S.,et al, 1985
Raised Intracranial Pressure Due to Large Intracranial Xanthoma
BMJ 288:1722-1723, Rees,A.,et al, 1984